Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
86.03
+3.02 (3.64%)
At close: Nov 6, 2026, 4:00 PM EST
88.00
+1.97 (2.29%)
After-hours: Nov 6, 2026, 7:30 PM EST
Dianthus Therapeutics Employees
Dianthus Therapeutics had 92 employees as of December 31, 2025. The number of employees increased by 14 or 17.95% compared to the previous year. That makes Dianthus Therapeutics the 31,942nd largest employer in the world and 4,106th in the United States.
Employees
92
Change (1Y)
14
Growth (1Y)
17.95%
Revenue / Employee
$29,543
Profits / Employee
-$2,197,000
Market Cap
4.84B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 92 | 14 | 17.95% |
| Dec 31, 2024 | 78 | 25 | 47.17% |
| Dec 31, 2023 | 53 | 21 | 65.63% |
| Jun 30, 2023 | 43 | - | - |
| Mar 31, 2023 | 32 | - | - |
| Dec 31, 2022 | 32 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 3,200 |
| PTC Therapeutics | 991 |
| Travere Therapeutics | 497 |
| CRISPR Therapeutics AG | 393 |
| Scholar Rock Holding | 289 |
| Cogent Biosciences | 258 |
| Kodiak Sciences | 141 |
| Edgewise Therapeutics | 127 |
DNTH News
- 4 days ago - Dianthus reports Q3 EPS (81c), consensus (95c) - TheFly
- 4 days ago - Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 2026 Financial Results - GlobeNewsWire
- 4 days ago - Dianthus Therapeutics Earnings release: Q3 2026 - Filings
- 4 days ago - Dianthus Therapeutics Quarterly report: Q3 2026 - Filings
- 6 days ago - Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 days ago - Dianthus Therapeutics to Participate in Five Investor Conferences During November - GlobeNewsWire
- 13 days ago - Dianthus initiated with a Buy at Roth Capital - TheFly
- 26 days ago - Dianthus Therapeutics Recognized Among Fortune's 2026 Best Workplaces In BioPharma - GlobeNewsWire